| abstract |
The invention relates to an antibody against an epitope comprised in the amino acid sequence encoded by variable exon 6 of the CD44 gene, to a hybridoma cell line, to an antibody derivative that can be obtained by chemical or enzymatic modification of this antibody, to an antibody. recombinant with the idiotype of this antibody, to a pharmaceutical composition comprising the antibody or derivative of this antibody as an active ingredient, and to the use of an antibody or antibody molecule in in vivo or out-of-body or human body diagnostic methods. à |